Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy

Shingo Miyamoto, Michinari Hirata, Ayano Yamazaki, Takuya Kageyama, Hidetoshi Hasuwa, Hiroto Mizushima, Yoshihiro Tanaka, Hiroshi Yagi, Kenzo Sonoda, Masahiro Kai, Hideo Kanoh, Hitoo Nakano, Eisuke Mekada

Research output: Contribution to journalArticlepeer-review

161 Citations (Scopus)

Fingerprint Dive into the research topics of 'Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences